US2016376330A1PendingUtilityA1
Mating factor alpha pro-peptide variants
Est. expiryFeb 28, 2034(~7.6 yrs left)· nominal 20-yr term from priority
Inventors:Per Noergaard
C07K 14/605C07K 14/395C12P 21/02C07K 2319/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is related to Mating Factor α pro-peptide variants useful for the recombinant expression of polypeptides comprising a GLP-1 peptide in yeasts. The invention is also related to DNA sequences, vectors and host cells for use in expressing polypeptides in yeasts.
Claims
exact text as granted — not AI-modified1 . A method for recombinant expression of a polypeptide comprising a GLP-1 peptide in yeast comprising the culturing of a yeast strain comprising a DNA sequence encoding a processing and secretion signal upstream of the polypeptide, wherein said processing and secretion signal comprises a Mating Factor α pro-peptide variant having at least one substitution in the VIGYL sequence at positions 38-42 to comprise the amino acid sequence of the general formula (I):
X 38 -X 39 -X 40 -X 41 -X 42 (SEQ ID NO:1) (I)
wherein
X 38 is F, L, I or V;
X 39 L, I, V or M;
X 40 is A, G, S, E, Q, Y, F, W, R, K, H, L, I, V or M;
X 41 is S, Y, F, W, L, I, V or M;
X 42 is Y, W, L, I, V, M or S;
with the proviso that X 38 -X 42 is not VIGYS.
2 . The method according to claim 1 wherein
X 38 is F, L or V;
X 39 L, I, V or M;
X 40 is G or R;
X 41 is S, Y, L, I, V or M, and
X 42 is Y, W, L, V or M.
3 . The method according to claim 1 wherein
X 38 is I or V;
X 39 L, I, V or M;
X 40 is A, G, S, E, Q, Y, F, W, R, K, H, L, I, V or M;
X 41 is Y, F, or W, and
X 42 is L or I.
4 . The method according to claim 1 wherein
X 38 is V;
X 39 L, I, V or M;
X 40 is G or R;
X 41 is Y, and
X 42 is L.
5 . The method according to claim 1 , wherein X 40 is R.
6 . The method according to claim 1 , wherein said Mating Factor α pro-peptide variant has less than 10 amino acid residue changes outside of the X 38 -X 42 sequence as compared to the Mating Factor α pro-peptide as set out in SEQ ID NO:2 (amino acid residues 20-85).
7 . The method according to claim 1 , wherein said yeast carries at least one genetic modification reducing its capacity for O-glycosylation.
8 . The method according to claim 7 , wherein the PMT1 gene in said yeast is deleted.
9 . The method according to claim 1 , wherein said polypeptide comprises GLP-1(9-37)[K34R] or GLP-1(9-37)[K34R,G37K].
10 . The method according to claim 1 , wherein said polypeptide consists of GLP-1(9-37)[K34R] or GLP-1(9-37)[K34R,G37K].
11 . The method according to claim 9 , wherein said polypeptide has an N-terminal extension.
12 . Mating Factor α pro-peptide variant having at least one substitution in the VIGYL sequence at positions 38-42 to comprise the amino acid sequence of the general formula (I):
X 38 -X 39 -X 40 -X 41 -X 42 (SEQ ID NO:1) (I)
wherein
X 38 is F, L, I or V;
X 39 L, I, V or M;
X 40 is A, G, S, E, Q, Y, F, W, R, K, H, L, I, V or M;
X 41 is S, Y, F, W, L, I, V or M;
X 42 is Y, W, L, I, V, M or S;
with the proviso that X 38 -X 42 is not VIGYS, VIDYS, VATYL, VIGYR, or AIGYL.
13 . GLP-1 precursor which is a fusion polypeptide comprising:
A pre-peptide, A Mating Factor α pro-peptide variant having at least one substitution in the VIGYL sequence at positions 38-42 to comprise the amino acid sequence of the general formula (I):
X 38 -X 39 -X 40 -X 41 -X 42 (SEQ ID NO:1) (I)
wherein X 38 is F, L, I or V; X 39 L, I, V or M; X 40 is A, G, S, E, Q, Y, F, W, R, K, H, L, I, V or M; X 41 is S, Y, F, W, L, I, V or M; X 42 is Y, W, L, I, V, M or S; with the proviso that X 38 -X 42 is not VIGYS, Optionally an extension peptide, and A GLP-1 peptide.
14 . Expression vector comprising a DNA sequence encoding the polypeptide according to claim 12 .
15 . Host cell comprising the expression vector according to claim 14 .Join the waitlist — get patent alerts
Track US2016376330A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.